Standardized 2 mg starting dose
Basak O, Beumer J, Wiebrands K, Seno H, van Oudenaarden A, Clevers H
The strongest evidence for meaningful, long-term weight loss and cardiometabolic benefit is at the labeled maintenance doses reached using a slow, individualized titration
These trials are evaluating retatrutide across several patient populations, including individuals with obesity, type 2 diabetes, and related metabolic conditions
For someone on GLP-1 therapy, this is one of the best possible breakfast choices small in volume, big in nutrition
Paired with a nutrient-rich diet, this supplement can help ensure your body gets the vitamins, minerals, and support it needs to thrive